The Microbiome as a Therapeutic Target for Metabolic Diseases

Obesity, type 2 diabetes, and fatty liver disease are now viewed through the lens of microbial imbalance. Specific gut microbes can influence energy extraction, lipogenesis, insulin sensitivity, and inflammation. This session discusses how diet, antibiotics, prebiotics, probiotics, and fecal microbiota transplantation (FMT) may serve as therapeutic strategies for metabolic syndrome, with emphasis on personalized microbial interventions based on individual microbiota profiles.

 

    Related Conference of The Microbiome as a Therapeutic Target for Metabolic Diseases

    August 25-26, 2025

    6th International Conference on Molecular Microbiology

    Singapore City, Singapore
    September 22-23, 2025

    13th World Congress and Expo on Applied Microbiology

    Dubai, UAE
    November 03-04, 2025

    54th World Congress on Microbiology

    Rome, Italy

    The Microbiome as a Therapeutic Target for Metabolic Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in